AstraZeneca’s Voydeya Gets US FDA Approval As Add On To Ultomiris And Soliris

 
• By Jessica Merrill
  
Plus sign
Voydeya is approved on top of Ultomiris or Soliris • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Rare Diseases

More from Scrip